Suppr超能文献

单次口服150微克L-甲状腺素对临床甲状腺功能正常的甲状腺肿患者血清甲状腺激素和促甲状腺激素浓度的影响。

Effect of a single oral dose of L-thyroxine (150 micrograms) on serum thyroid hormone and TSH concentrations in clinically euthyroid goitrous patients.

作者信息

Carpi A, Toni M G, De Gaudio C

机构信息

Medical Clinic II, University of Pisa, Italy.

出版信息

Thyroidology. 1992 Aug;4(2):69-73.

PMID:1285029
Abstract

Serum TT4, FT4, TT3, FT3 and TSH, concentrations were measured before and 0.5, 1, 2, 3, 4, 5 hours after a single oral dose of L-T4 (150 micrograms) in 21 clinically euthyroid goitrous patients on a long-term therapy program. The mean basal TT4 concentration, 8.85 +/- 0.52 micrograms/dl (mean +/- se), increased significantly at the second hour (10.04 +/- 0.52 micrograms/dl, p < 0.001) and reached the highest value at the third hour (10.35 +/- 0.55 microgram/dl, p < 0.001). Subsequently the mean serum TT4 concentration remained elevated until the fifth hour (10.20 + 0.60 microgram/dl, p < 0.001). The mean basal value of FT4 concentration, 8.66 +/- 0.40 pg/ml, increased significantly at 30 minutes (9.19 +/- 0.40 pg/ml, p < 0.01) and reached the highest value at the third hour (11.81 +/- 0.56 pg/ml, p < 0.001). The mean basal serum FT3 concentration, 3.56 +/- 0.10 pg/ml, increased significantly 30 minutes (3.72 +/- 0.11 pg/ml p < 0.05) after L-T4 administration; the mean serum FT3 concentration was significantly higher than the basal level and 1 and 2 hours as well, and reached the highest value at the third hour (3.86 +/- 0.09 pg/ml). The mean serum TT3 concentration did not show any significant change at any time. The mean basal TSH value (2.73 +/- 0.42 microUI/ml) declined progressively. At 30 minutes it decreased significantly (2.29 +/- 0.38 microUI/ml, p < 0.01) and reached the lowest value at the fifth hour (1.39 +/- 0.26 microUI/ml, p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在21例接受长期治疗方案的临床甲状腺功能正常的甲状腺肿患者中,单次口服L-T4(150微克)前及服药后0.5、1、2、3、4、5小时测定血清总甲状腺素(TT4)、游离甲状腺素(FT4)、总三碘甲状腺原氨酸(TT3)、游离三碘甲状腺原氨酸(FT3)及促甲状腺激素(TSH)浓度。基础TT4平均浓度为8.85±0.52微克/分升(平均值±标准误),在第2小时显著升高(10.04±0.52微克/分升,p<0.001),并在第3小时达到最高值(10.35±0.55微克/分升,p<0.001)。随后,血清TT4平均浓度一直升高至第5小时(10.20+0.60微克/分升,p<0.001)。基础FT4浓度平均值为8.66±0.40皮克/毫升,在30分钟时显著升高(9.19±0.40皮克/毫升,p<0.01),并在第3小时达到最高值(11.81±0.56皮克/毫升,p<0.001)。基础血清FT3浓度平均值为3.56±0.10皮克/毫升,在服用L-T4后30分钟显著升高(3.72±0.11皮克/毫升,p<0.05);血清FT3平均浓度在1小时和2小时时也显著高于基础水平,并在第3小时达到最高值(3.86±0.09皮克/毫升)。血清TT3平均浓度在任何时候均未显示出任何显著变化。基础TSH平均值(2.73±0.42微国际单位/毫升)逐渐下降。在30分钟时显著降低(2.29±0.38微国际单位/毫升,p<0.01),并在第5小时达到最低值(1.39±0.26微国际单位/毫升,p<0.001)。(摘要截选至250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验